Viral Infections in BAL and Bronchial Biopsies of Stable COPD Patients
Human Rhinovirus and Respiratory Syncytial Virus From Bronchoalveolar Lavage and Bronchial Biopsies of Selected Patients With Stable Chronic Obstructive Pulmonary Disease.
1 other identifier
observational
53
0 countries
N/A
Brief Summary
Background: The presence of low-grade viral infection in the airways of patients with stable chronic obstructive pulmonary disease (COPD) could potentially have implications in the pathogenesis and progression of the disease, but previous studies have reported very different rates of human rhinovirus (HRV) and respiratory syncytial virus (RSV) genome detection in nasal and sputum samples. However, no study has investigated the presence of these viruses directly in the lungs by bronchoalveolar lavage (BAL) and bronchial biopsies. This study aimed to investigate whether HRV and RSV are present in the lungs of stable COPD patients by performing BAL and bronchial biopsies, and relate their presence with disease severity. Methods: Consecutive patients with stable COPD and control subjects, who underwent diagnostic (e.g., lung cancer) and/or therapeutic (e.g., hemoptysis) fibreoptic bronchoscopy in a university hospital in Athens, Greece, were enrolled. The collected BAL and bronchial biopsies during bronchoscopy were subsequently processed for HRV and RSV RNA detection with real-time polymerase chain reaction (PCR). More specifically, the nucleocapsid gene and 5΄ non-coding region were searched for RSV and HRV detection, respectively.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Nov 2010
Longer than P75 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2010
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 1, 2014
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2014
CompletedFirst Submitted
Initial submission to the registry
December 2, 2015
CompletedFirst Posted
Study publicly available on registry
December 4, 2015
CompletedDecember 7, 2015
December 1, 2015
4 years
December 2, 2015
December 4, 2015
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
HRV AND RSV PRESENCE
A Nucleocapsid (N) gene partial sequence, as well as a 5΄ non-coding region (5΄NCR) partial sequence were amplified for RSV and HRV, respectively.
7 days
Study Arms (5)
COPD I
BRONCHOSCOPIC PROCEDURE IN COPD PATIENTS STAGE I
COPD II
BRONCHOSCOPIC PROCEDURE IN COPD PATIENTS STAGE II
COPD III
BRONCHOSCOPIC PROCEDURE IN COPD PATIENTS STAGE III
NONSMOKERS
BRONCHOSCOPIC PROCEDURE IN NONSMOKERS
CURRENT OR EXSMOKERS
BRONCHOSCOPIC PROCEDURE IN CURRENT OR EXSMOKERS
Interventions
After the routine bronchoscopic inspection of the tracheobronchial tree, the investigators performed BAL from subsegmental bronchi and bronchial biopsies (3-4 per patient) from non infiltrated carina
Eligibility Criteria
We enrolled 31 patients with COPD and 22 control subjects. The most common symptoms were dyspnea (32%), cough (19%) and hemoptysis (13%). Whereas 47% of participants did not mention any symptom, but referred to our department in order to investigate bronchoscopically abnormal radiographic findings revealed in chest computed tomography. The commonest comorbidities of COPD patients were arterial hypertension (47%), hyperlipidemia (20.7%) and coronary artery disease (17%), and of control subjects arterial hypertension (50%), hyperlipidemia (22,7%) and diabetes mellitus type 2 (13,6%).
You may qualify if:
- stable COPD,indication for bronchoscopic procedure
You may not qualify if:
- atopic history, asthma, extensive pleural effusions, bronchiectasis, immunosuppression due to chemotherapy or systemic corticosteroids and all the contraindications of the bronchoscopic procedures
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Publications (3)
Falsey AR, Formica MA, Hennessey PA, Criddle MM, Sullender WM, Walsh EE. Detection of respiratory syncytial virus in adults with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006 Mar 15;173(6):639-43. doi: 10.1164/rccm.200510-1681OC. Epub 2005 Dec 30.
PMID: 16387798BACKGROUNDSeemungal T, Harper-Owen R, Bhowmik A, Moric I, Sanderson G, Message S, Maccallum P, Meade TW, Jeffries DJ, Johnston SL, Wedzicha JA. Respiratory viruses, symptoms, and inflammatory markers in acute exacerbations and stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2001 Nov 1;164(9):1618-23. doi: 10.1164/ajrccm.164.9.2105011.
PMID: 11719299BACKGROUNDSethi S, Maloney J, Grove L, Wrona C, Berenson CS. Airway inflammation and bronchial bacterial colonization in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2006 May 1;173(9):991-8. doi: 10.1164/rccm.200509-1525OC. Epub 2006 Feb 10.
PMID: 16474030BACKGROUND
Biospecimen
BAL and bronchial biopsies
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
GEORGIOS ARSENIS, PROFESSOR
University of Athens
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Resident in Respiratory Medicine
Study Record Dates
First Submitted
December 2, 2015
First Posted
December 4, 2015
Study Start
November 1, 2010
Primary Completion
November 1, 2014
Study Completion
November 1, 2014
Last Updated
December 7, 2015
Record last verified: 2015-12
Data Sharing
- IPD Sharing
- Will not share